Clinical trials
Completed Observational trials in Malawi
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 9 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 60 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of North Carolina, Chapel Hill | 9 |
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 4 |
| Microbicide Trials Network | 3 |
| University of Liverpool | 3 |
| Boston University | 2 |
| COVID-19 Prevention Network | 2 |
| Centers for Disease Control and Prevention | 2 |
| Foundation for Innovative New Diagnostics, Switzerland | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 11 |
| Tuberculosis | 6 |
| Malaria | 5 |
| Acquired Immunodeficiency Syndrome | 4 |
| COVID-19 | 3 |
| Disease | 2 |
| Fistula | 2 |
| Malaria, Falciparum | 2 |
| Asthma | 1 |
| Bacterial Infections | 1 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.